Skip to main content
. 2016 Jun 13;82(13):3846–3856. doi: 10.1128/AEM.00665-16

TABLE 2.

Specific and relative activities for the KES23458 R414K variant compared to the WTa

Substrate R414K sp act (nmol/min/mg) Relative activity (% of WT)
β-Alanine 75.1 ± 1.0 19.9
12-Aminododecanoic acid ND ND
Putrescine 38.6 ± 2.0 14.4
Cadaverine 57.9 ± 1.0 9.6
1,3-Diaminopropane 5.1 ± 1.0 20.5
a

Note that for each substrate, the acceptor used was pyruvate. Assay conditions are described in Materials and Methods (and included potassium phosphate buffer at 100 mM, pH 10). ND, activity not determined.